• SENSEX
    NIFTY 50
Healthcare

AstraZeneca COVID-19 Vaccine study paused after one illness

Updated : September 09, 2020 07:29 AM IST

In a statement issued Tuesday evening, the company said its standard review process triggered a pause to vaccination to allow review of safety data.
AstraZeneca didn’t reveal any information about the possible side effect except to call it a potentially unexplained illness.
AstraZeneca COVID-19 Vaccine study paused after one illness

You May Also Like

Live TV
Advertisement